\(5-HT_{2A/2C}\) antagonist used in migraine
Methysergide is a serotonin receptor antagonist primarily targeting the \(5-HT_{2A}\) and \(5-HT_{2C}\) receptors. It has been used as a prophylactic treatment for migraine by preventing vasoconstriction and platelet aggregation associated with migraine attacks. - Methysergide blocks serotonin-induced vasoconstriction, thereby reducing migraine frequency.
- Ketanserin is also a \(5-HT_{2}\) antagonist but primarily used as an antihypertensive agent.
- Sumatriptan and Rizatriptan are \(5-HT_{1B/1D}\) receptor agonists (triptans) used for acute migraine treatment, not antagonists.
Hence, Methysergide is the correct drug categorized as a \(5-HT_{2A/2C}\) antagonist used in migraine prophylaxis.
List - I | List - II |
---|---|
A) Morphine | IV) Pain killer |
B) Cannabinoids | V) Dopamine |
C) Cocaine | I) Cardiovascular system |
D) Benzodiazepines | II) Tranquilizers |
Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing